Femara (Letrozole)
Company: Novartis (Switzerland) Usage: oral Description Femara (Letrozole) Femara (Letrozole) is an oral aromatase inhibitor of third generation. Originally its mission was to treat breast cancer in women. The thing is that many forms of cancer in women are estrogen dependent. Thus, by blocking aromatase Femara can reduce estrogen production …